AAAAAA

   
Results: 1-10 |
Results: 10
Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication
Authors: Hashemi, FB Mollenhauer, U Madsen, LD Sha, BE Nacken, W Moyer, MB Sorg, C Spear, GT
Citation: Fb. Hashemi et al., Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication, AIDS, 15(4), 2001, pp. 441-449
Body composition in HIV-infected women
Authors: Swanson, B Hershow, RC Sha, BE Benson, CA Cohen, M Gunfeld, C
Citation: B. Swanson et al., Body composition in HIV-infected women, NUTRITION, 16(11-12), 2000, pp. 1064-1068
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels
Authors: Sha, BE Johnson, VA Kendall, MA Haubrich, R Nokta, M Lamb, K Zackin, RA Nail, CD Currier, JS
Citation: Be. Sha et al., Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels, AIDS, 14(6), 2000, pp. 746-748
Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy
Authors: Tenorio, AR Irlanda, IE Narkiewicz, E Smith, KY Kessler, HA Sha, BE
Citation: Ar. Tenorio et al., Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy, AIDS, 14(10), 2000, pp. 1470-1471
Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
Authors: Sha, BE Proia, LA Kessler, HA
Citation: Be. Sha et al., Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers, J AM MED A, 284(21), 2000, pp. 2723-2723
Bacterial vaginosis-associated microflora isolated from the female genitaltract activates HIV-1 expression
Authors: Al-Harthi, L Roebuck, KA Olinger, GG Landay, A Sha, BE Hashemi, FB Spear, GT
Citation: L. Al-harthi et al., Bacterial vaginosis-associated microflora isolated from the female genitaltract activates HIV-1 expression, J ACQ IMM D, 21(3), 1999, pp. 194-202
Levels of proinflammatory cytokines in plasma after pneumococcal immunization in human immunodeficiency virus type 1-infected patients
Authors: Valdez, H Purvis, S Asaad, R Valerio, I Sha, BE Landay, AL Lederman, MM
Citation: H. Valdez et al., Levels of proinflammatory cytokines in plasma after pneumococcal immunization in human immunodeficiency virus type 1-infected patients, CL DIAG LAB, 6(3), 1999, pp. 427-428
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero
Authors: Olivero, OA Shearer, GM Chougnet, CA Kovacs, AAS Landay, AL Baker, R Stek, AM Khoury, MM Proia, LA Kessler, HA Sha, BE Tarone, RE Poirier, MC
Citation: Oa. Olivero et al., Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero, AIDS, 13(8), 1999, pp. 919-925
Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1
Authors: Olinger, GG Hashemi, FB Sha, BE Spear, GT
Citation: Gg. Olinger et al., Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1, AIDS, 13(14), 1999, pp. 1905-1912
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection
Authors: Jacobson, JM Spritzler, J Fox, L Fahey, JL Jackson, JB Chernoff, M Wohl, DA Wu, AW Hooton, TM Sha, BE Shikuma, CM MacPhail, LA Simpson, DM Trapnell, CB Basgoz, N
Citation: Jm. Jacobson et al., Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection, J INFEC DIS, 180(1), 1999, pp. 61-67
Risultati: 1-10 |